Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Santiago, Jose A ^a   Potashkin, Judith A ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INSULIN; INSULIN RECEPTOR; LIPID; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NERVE DEGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA ISOLATION; SIGNAL TRANSDUCTION; ALGORITHM; BLOOD; DIABETES MELLITUS, TYPE 2; GENETICS; METABOLISM; MIDDLE AGED; PROGNOSIS; STATISTICS; SYSTEMS BIOLOGY;

ALGORITHMS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROGNOSIS; STOCHASTIC PROCESSES; SYSTEMS BIOLOGY;

EID: 84893511983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083940     Document Type: Article

References (41)

1. Santiago JA, Potashkin JA (2013) Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends Mol Med 19: 176-186.
2. Hardy J, Lewis P, Revesz T, Lees A, Paisan-Ruiz C (2009) The genetics of Parkinson's syndromes: a critical review. Current opinion in genetics & development 19: 254-265.
3. Scheele C, Nielsen AR, Walden TB, Sewell DA, Fischer CP, et al. (2007) Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? Faseb J 21: 3653-3665. (Pubitemid 350075153)
4. Jain D, Jain R, Eberhard D, Eglinger J, Bugliani M, et al. (2012) Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes. J Mol Cell Biol 4: 221-230.
5. Aviles-Olmos I, Dickson J, Kefalopoulou Z, Djamshidian A, Ell P, et al. (2013) Exenatide and the treatment of patients with Parkinson's disease. J Clin Invest 123: 2730-2736.
6. Wahlqvist ML, Lee MS, Hsu CC, Chuang SY, Lee JT, et al. (2012) Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat Disord 18: 753-758.
7. Furlong LI (2013) Human diseases through the lens of network biology. Trends Genet 29: 150-159.
8. Barabasi AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12: 56-68.
9. Park J, Lee DS, Christakis NA, Barabasi AL (2009) The impact of cellular networks on disease comorbidity. Mol Syst Biol 5: 262.
10. Hwang D, Lee IY, Yoo H, Gehlenborg N, Cho JH, et al. (2009) A systems approach to prion disease. Mol Syst Biol 5: 252.
11. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, et al. (2007) The human disease network. Proc Natl Acad Sci U S A 104: 8685-8690. (Pubitemid 47175372)
12. Edwards YJ, Beecham GW, Scott WK, Khuri S, Bademci G, et al. (2011) Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS One 6: e16917.
13. Liu M, Liberzon A, Kong SW, Lai WR, Park PJ, et al. (2007) Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet 3: e96.
14. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, et al. (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8: 615.
15. Kohler S, Bauer S, Horn D, Robinson PN (2008) Walking the interactome for prioritization of candidate disease genes. Am J Hum Genet 82: 949-958.
16. Le DH, Kwon YK (2012) GPEC: a Cytoscape plug-in for random walk-based gene prioritization and biomedical evidence collection. Comput Biol Chem 37: 17-23.
17. Linghu B, Snitkin ES, Hu Z, Xia Y, Delisi C (2009) Genome-wide prioritization of disease genes and identification of disease-disease associations from an integrated human functional linkage network. Genome Biol 10: R91.
18. Montojo J, Zuberi K, Rodriguez H, Kazi F, Wright G, et al. (2010) GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop. Bioinformatics 26: 2927-2928.
19. Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, et al. (2011) Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Mov Disord 26: 2283-2286.
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184.
21. Potashkin JA, Santiago JA, Ravina BM, Watts A, Leontovich AA (2012) Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients. PLoS One 7: e43595.
22. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, et al. (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104: 955-960. (Pubitemid 46154718)
23. Aviles-Olmos I, Limousin P, Lees A, Foltynie T (2013) Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 136: 374-384.
24. Reiner A, Yekutieli D, Benjamini Y (2003) Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19: 368-375. (Pubitemid 36284936)
25. Karolina DS, Armugam A, Tavintharan S, Wong MT, Lim SC, et al. (2011) MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 6: e22839.
26. Navlakha S, Kingsford C (2010) The power of protein interaction networks for associating genes with diseases. Bioinformatics 26: 1057-1063.
27. Cereda E, Barichella M, Cassani E, Caccialanza R, Pezzoli G (2012) Clinical features of Parkinson disease when onset of diabetes came first: A case-control study. Neurology 78: 1507-1511.
28. Molochnikov L, Rabey JM, Dobronevsky E, Bonucelli U, Ceravolo R, et al. (2012) A molecular signature in blood identifies early Parkinson's disease. Molecular neurodegeneration 7: 26.
29. Shehadeh LA, Yu K, Wang L, Guevara A, Singer C, et al. (2010) SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One 5: e9104.
30. Santiago JA, Scherzer CR, Study HB, Potashkin JA (in press) Specific splice variants are associated with Parkinson's disease. Mov Disord.
31. Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870. (Pubitemid 26296755)
32. Buongiorno M, Compta Y, Marti MJ (2011) Amyloid-beta and tau biomarkers in Parkinson's disease-dementia. J Neurol Sci 310: 25-30.
33. Westmark CJ (2013) What's hAPPening at synapses? The role of amyloid beta-protein precursor and beta-amyloid in neurological disorders. Mol Psychiatry 18: 425-434.
34. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, et al. (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci U S A 98: 12245-12250. (Pubitemid 32959858)
35. Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, et al. (2013) Cerebrospinal fluid amyloid-beta and phenotypic heterogeneity in de novo Parkinson's disease. J Neurol Neurosurg Psychiatry 84: 537-543.
36. Tu Z, Keller MP, Zhang C, Rabaglia ME, Greenawalt DM, et al. (2012) Integrative analysis of a cross-loci regulation network identifies App as a gene regulating insulin secretion from pancreatic islets. PLoS Genet 8: e1003107.
37. Bosco D, Plastino M, Cristiano D, Colica C, Ermio C, et al. (2012) Dementia is associated with insulin resistance in patients with Parkinson's disease. J Neurol Sci 315: 39-43.
38. Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, et al. (2012) Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 79: 659-667.
39. Palacios N, Gao X, McCullough ML, Jacobs EJ, Patel AV, et al. (2011) Obesity, diabetes, and risk of Parkinson's disease. Mov Disord 26: 2253-2259.
40. Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, et al. (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72: 893-901.
41. Cereda E, Barichella M, Pedrolli C, Klersy C, Cassani E, et al. (2011) Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 34: 2614-2623.